Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Human Papillomavirus
Investigators at University of Manchester target human papillomavirus
July 2nd, 2008
According to recent research from Manchester, the United Kingdom, " To assess the feasibility and acceptability of delivering a human papillomavirus (HPV) vaccine to adolescent girls. Prospective cohort study." "Setting 36 secondary schools in two primary care trusts in Greater Manchester, United Kingdom. Participants 2817 schoolgirls in year 8 (12 and 13 Year olds). Delivery of the bivalent vaccine at 0, 1, and 6 months over one school year. Main outcome measures Vaccine-uptake for doses 1 and 2 of a three dose schedule. Vaccine uptake was 70.6% (1989/2817) for the first dose and 68.5% (1930/2817) for the second close. Uptake was significantly tower in schools with...
Source: Vaccine Weekly (2008-07-02)
|
